Clinical characterisation of sensory neuropathy with anti-FGFR3 autoantibodies
Clinical characterisation of sensory neuropathy with anti-FGFR3 autoantibodies
Objective. Sensory neuropathies (SNs) are often classified as idiopathic even if immunological mechanisms can be suspected. Antibodies against the intracellular domain of the fibroblast growth factor receptor 3 (FGFR3) possibly identify a subgroup of SN affecting mostly the dorsal root ganglion (DRG). The aim of this study was to identify the frequency of anti-FGFR3 antibodies and the associated clinical pattern in a large cohort of patients with SN.
Methods. A prospective, multicentric, European and Brazilian study included adults with pure SN. Serum anti-FGRF3 antibodies were analysed by ELISA. Detailed clinical and paraclinical data were collected for each anti-FGFR3-positive patient and as control for anti-FGFR3-negative patients from the same centres (‘center-matched’).
Results. Sixty-five patients out of 426 (15%) had anti-FGFR3 antibodies, which were the only identified autoimmune markers in 43 patients (66%). The neuropathy was non-length dependent in 89% and classified as sensory neuronopathy in 64%, non-length-dependent small fibre neuropathy in 17% and other neuropathy in 19%. Specific clinical features occurred after 5–6 years of evolution including frequent paresthesia, predominant clinical and electrophysiological involvement of the lower limbs, and a less frequent mixed large and small fibre involvement. Brazilians had a higher frequency of anti-FGFR3 antibodies than Europeans (36% vs 13%, p<0.001), and a more frequent asymmetrical distribution of symptoms (OR 169, 95% CI 3.4 to 8424).
Conclusions. Anti-FGFR3 antibodies occur in a subgroup of SN probably predominantly affecting the DRG. Differences between Europeans and Brazilians could suggest involvement of genetic or environmental factors.
1-9
Tholance, Yannick
f36f75bd-8f5a-482c-9224-767b5e90434a
Moritz, Christian Peter
fa896948-260b-48ac-a986-5aeae211fb6d
Rosier, Carole
4f554fbf-f31f-4906-8286-f4f4db73f91d
Ferraud, Karine
7e95843f-b79d-43bf-a16d-b83ad2ee1207
Lassablière, François
f5dae072-6a68-47db-a61f-1146a4034ae4
Reynaud-Federspiel, Evelyne
2203ffda-d053-4421-8f8a-db4d216b06f0
França Jr, Marcondes C.
31e8b208-e5de-4cfb-b008-347b0160c6dd
Martinez, Alberto R.M.
27d665e0-b120-4857-b45b-04d6802cc34b
Camdessanché, Jean-Philippe
14c289af-226f-40b9-9900-c6fea73e6858
Antoine, Jean-Christophe
89fa0974-f2f6-4a48-b4c1-ea8739328570
Galea, Ian
66209a2f-f7e6-4d63-afe4-e9299f156f0b
Anti-FGFR3 antibody Study Group
Tholance, Yannick
f36f75bd-8f5a-482c-9224-767b5e90434a
Moritz, Christian Peter
fa896948-260b-48ac-a986-5aeae211fb6d
Rosier, Carole
4f554fbf-f31f-4906-8286-f4f4db73f91d
Ferraud, Karine
7e95843f-b79d-43bf-a16d-b83ad2ee1207
Lassablière, François
f5dae072-6a68-47db-a61f-1146a4034ae4
Reynaud-Federspiel, Evelyne
2203ffda-d053-4421-8f8a-db4d216b06f0
França Jr, Marcondes C.
31e8b208-e5de-4cfb-b008-347b0160c6dd
Martinez, Alberto R.M.
27d665e0-b120-4857-b45b-04d6802cc34b
Camdessanché, Jean-Philippe
14c289af-226f-40b9-9900-c6fea73e6858
Antoine, Jean-Christophe
89fa0974-f2f6-4a48-b4c1-ea8739328570
Galea, Ian
66209a2f-f7e6-4d63-afe4-e9299f156f0b
Tholance, Yannick, Moritz, Christian Peter, Rosier, Carole, Ferraud, Karine, Lassablière, François, Reynaud-Federspiel, Evelyne, França Jr, Marcondes C., Martinez, Alberto R.M., Camdessanché, Jean-Philippe, Antoine, Jean-Christophe and Galea, Ian
,
Anti-FGFR3 antibody Study Group
(2019)
Clinical characterisation of sensory neuropathy with anti-FGFR3 autoantibodies.
Journal of Neurology Neurosurgery and Psychiatry, .
(doi:10.1136/jnnp-2019-321849).
Abstract
Objective. Sensory neuropathies (SNs) are often classified as idiopathic even if immunological mechanisms can be suspected. Antibodies against the intracellular domain of the fibroblast growth factor receptor 3 (FGFR3) possibly identify a subgroup of SN affecting mostly the dorsal root ganglion (DRG). The aim of this study was to identify the frequency of anti-FGFR3 antibodies and the associated clinical pattern in a large cohort of patients with SN.
Methods. A prospective, multicentric, European and Brazilian study included adults with pure SN. Serum anti-FGRF3 antibodies were analysed by ELISA. Detailed clinical and paraclinical data were collected for each anti-FGFR3-positive patient and as control for anti-FGFR3-negative patients from the same centres (‘center-matched’).
Results. Sixty-five patients out of 426 (15%) had anti-FGFR3 antibodies, which were the only identified autoimmune markers in 43 patients (66%). The neuropathy was non-length dependent in 89% and classified as sensory neuronopathy in 64%, non-length-dependent small fibre neuropathy in 17% and other neuropathy in 19%. Specific clinical features occurred after 5–6 years of evolution including frequent paresthesia, predominant clinical and electrophysiological involvement of the lower limbs, and a less frequent mixed large and small fibre involvement. Brazilians had a higher frequency of anti-FGFR3 antibodies than Europeans (36% vs 13%, p<0.001), and a more frequent asymmetrical distribution of symptoms (OR 169, 95% CI 3.4 to 8424).
Conclusions. Anti-FGFR3 antibodies occur in a subgroup of SN probably predominantly affecting the DRG. Differences between Europeans and Brazilians could suggest involvement of genetic or environmental factors.
Text
Tholance et al_postprint
- Accepted Manuscript
More information
Accepted/In Press date: 28 October 2019
e-pub ahead of print date: 5 November 2019
Identifiers
Local EPrints ID: 436041
URI: http://eprints.soton.ac.uk/id/eprint/436041
ISSN: 0022-3050
PURE UUID: ffd4dde7-30ce-4952-b117-b98c7c23389c
Catalogue record
Date deposited: 26 Nov 2019 17:30
Last modified: 17 Mar 2024 02:57
Export record
Altmetrics
Contributors
Author:
Yannick Tholance
Author:
Christian Peter Moritz
Author:
Carole Rosier
Author:
Karine Ferraud
Author:
François Lassablière
Author:
Evelyne Reynaud-Federspiel
Author:
Marcondes C. França Jr
Author:
Alberto R.M. Martinez
Author:
Jean-Philippe Camdessanché
Author:
Jean-Christophe Antoine
Corporate Author: Anti-FGFR3 antibody Study Group
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
Loading...
View more statistics